Horizon Therapeutics

Activities: Manufacturing Ingredients Pharmaceutical

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part II Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
  4. Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer Denis will be responsible for optimising global operations for the company
  5. SeaBeLife awarded over €1.5 million in i-Nov innovation competition Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Regulatory

Horizon Pharma to leverage Medidata Clinical Cloud and eTMF

Medidata will increase efficiency for Horizon Pharma by managing its clinical research on a unified cloud platform
Finance

Horizon Pharma pursues Depomed with US$3bn hostile bid

Aims to combine its rare disease business with Depomed's pain treatments
Finance

Horizon Pharma to purchase Hyperion Therapeutics for US$1.1bn

Expands orphan drug business with the addition of two treatments for rare metabolic conditions
Finance

Horizon Pharma to buy Vidara Therapeutics International for US$660m

US company aims to take advantage of lower tax rates in Ireland
Subscribe now